Transgender
Conditions
Brief summary
Prospective observational study and biobank in all persons referred to CKIO * Patient involvement and quality of life * Population characteristics regarding hormone levels, safety parameters and clinical outcome before and after gender affirming hormone treatment.
Detailed description
This is a prospective observational cohort study including all patients referred to the Center of Gender Identity Odense. The purpose is to follow patients yearly to observe patient reported outcomes and control the quality and effects of the clinical treatment.
Interventions
None listed
Sponsors
Odense University Hospital
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* All Individuals with gender dysforia who are referred to Center of Gender Identity Odense * Age 18+
Exclusion criteria
°There are no
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Patient reported outcomes (PRO) | Every 52 weeks | Questionnaires |
| Hormone levels | Every 52 weeks | Blood samples |
| Safety parameters | Every 52 weeks | Blood samples |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Hair cortisol | Every 52 weeks | Hair samples 3 mm thick from the back of the head |
| Blood pressure | Every 52 weeks | Blood pressure measured in a sitting position |
| Spirometry | Every 52 weeks | Forced vital capacity is measured by a spirometer |
| Cortisol metabolism | Every 52 weeks | 24 hour urine samples |
| Body mass index | Every 52 weeks | Body mass index calculated from height an weight |
| Body weight | Every 52 weeks | Body weight measured on a scale in kilogram |
Countries
Denmark
Outcome results
None listed